Preanalytical approaches to improve recovery of amyloid-β peptides from CSF as measured by immunological or mass spectrometry-based assays

Overview of attention for article published in Alzheimer's Research & Therapy, November 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

news: 2 news outlets

twitter: 1 X user

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 39 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

Preanalytical approaches to improve recovery of amyloid-β peptides from CSF as measured by immunological or mass spectrometry-based assays.

Alzforum, 07 Dec 2018

Schauer SP, Mylott WR Jr, Yuan M, Jenkins RG, Rodney Mathews W, Honigberg LA, Wildsmith KR.

Preanalytical approaches to improve recovery of amyloid peptides from CSF as measured by immunological or mass spectrometrybased assays

Bioportfolio, 28 Nov 2018

Amyloid -β 1–42 (Aβ1–42) peptide is a well-established cerebrospinal fluid (CSF) biomarker for Alzheimer’s disease (AD).

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.